Relationship between Subclinical Thyroid Dysfunction and the Risk of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Cohort Studies
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Background. Evidence on the association between subclinical thyroid dysfunction and the risk of cardiovascular outcomes are conflicting. Methods and Results. PubMed, EMbase, Web of Science, Cochrane Library, and China Biology Medicine (CBM) databases were searched from inception to July 10, 2016. A total of 16 studies were included for meta-analysis. We found that subclinical hypothyroidism was not correlated with coronary heart disease (CHD) (RR = 1.17; 95% CI, 0.91–1.52), total mortality (RR = 1.02; 95% CI, 0.93–1.13), cardiovascular mortality (RR = 1.06; 95% CI, 0.77–1.45), heart failure (RR = 1.17; 95% CI, 0.87–1.57), and atrial fibrillation (RR = 1.05; 95% CI, 0.91–1.21), except CHD mortality (RR = 1.37; 95% CI, 1.03–1.84). Subgroup analysis indicated a higher estimation risk in CHD (RR = 1.54; 95% CI, 1.00–2.39), cardiovascular mortality (RR = 2.14; 95% CI, 1.43–3.22), and CHD mortality (RR = 1.54; 95% CI, 1.11–2.15) among participants < 65 years. Furthermore, subclinical hyperthyroidism was found to be associated with CHD (RR = 1.20; 95% CI, 1.02–1.42), total mortality (RR = 1.27; 95% CI, 1.07–1.51), and CHD mortality (RR = 1.45; 95% CI, 1.12–1.86). Conclusions. Subclinical hypothyroidism is likely associated with an increased risk of CHD mortality, and subclinical hyperthyroidism is likely associated with increased risk of CHD, CHD mortality, and total mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396 · cited 1×
“accordance with the Newcastle-Ottawa Quality Assessment Scale (NOS), which is a validated scale for nonrandomized studies in meta-analyses [36].”
MethodThe Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418 · cited 1×
“Subclinical thyroid dysfunction (SCTD) is defined as an abnormal serum thyroid-stimulating hormone (TSH) level, with normal concentrations of free thyroxine (T4) and free triiodothyronine (T3) [1, 2].”
BackgroundSubclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
Rodondi, N., den Elzen, W. P. J., Bauer, D. C., Cappola, A. R., Razvi, S., Walsh, J. P., Åsvold, B. O., Iervasi, G., Imaizumi, M., Collet, T.-H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1361 · Cited by 1,216
Cooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039 · cited 2×
“However, early screening and treatment of SCTD are still controversial on the basis of current evidence [1, 8].”
BackgroundThyroid Status, Disability and Cognitive Function, and Survival in Old Age
Gussekloo, J. (2004) · JAMA · doi:10.1001/jama.292.21.2591 · Cited by 899 · cited 3×
“Exclusion of studies with particular population [42] 1.”
BackgroundThyroid Status, Cardiovascular Risk, and Mortality in Older Adults
Cappola, A. R., Fried, L. P., Arnold, A. M., Danese, M. D., Kuller, L. H., Burke, G. L., Tracy, R. P., & Ladenson, P. W. (2006) · JAMA · doi:10.1001/jama.295.9.1033 · Cited by 862 · cited 1×
“Seven studies [21, 23, 24, 33, 40, 42, 43] (1347 cardiovascular mortality events) reported the relationship between subclinical hyperthyroidism and cardiovascular mortality (Figure 2(c)).”
BackgroundParle, J. V., Maisonneuve, P., Sheppard, M. C., Boyle, P., & Franklyn, J. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06067-6 · Cited by 669 · cited 4×
“84) based on six studies [5, 21, 34, 38, 42, 43] (1369 CHD mortality events) (Figure 3(a)).”
BackgroundInfluentialSubclinical hyperthyroidism and the risk of coronary heart disease and mortality
Collet, T.-H., Gussekloo, J., Bauer, D. C., den Elzen, W. P. J., Cappola, A. R., Balmer, P., Iervasi, G., Åsvold, B. O., Sgarbi, J. A., Völzke, H., et al. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.402 · Cited by 572
Thyroid Function Is Associated with Components of the Metabolic Syndrome in Euthyroid Subjects
Roos, A., Bakker, S. J. L., Links, T. P., Gans, R. O. B., & Wolffenbuttel, B. H. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1718 · Cited by 542
Subclinical thyroid dysfunction as a risk factor for cardiovascular disease
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2467 · Cited by 536 · cited 1×
“Seven studies [21, 23, 24, 33, 40, 42, 43] (1347 cardiovascular mortality events) reported the relationship between subclinical hyperthyroidism and cardiovascular mortality (Figure 2(c)).”
BackgroundSubclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death
Rodondi, N., Newman, A. B., Vittinghoff, E., de Rekeneire, N., Satterfield, S., Harris, T. B., & Bauer, D. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2460 · Cited by 503
Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality
Ochs, N., Auer, R., Bauer, D. C., Nanchen, D., Gussekloo, J., Cornuz, J., & Rodondi, N. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00225 · Cited by 477 · cited 2×
“For the association between subclinical hypothyroidism and CHD, total, and cardiovascular mortality, our results are consistent with previous meta-analyses [27, 28].”
ResultBiondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323
Singh, S., Duggal, J., Molnar, J., Maldonado, F., Barsano, C. P., & Arora, R. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.02.027 · Cited by 243 · cited 1×
“Although some meta-analyses [29, 45] reported significant associations between subclinical hypothyroidism and CHD, previous meta-analyses included case-control and crosssection studies, which could not accurately reflect a causeand-effect relationship.”
ResultNanchen, D., Gussekloo, J., Westendorp, R. G. J., Stott, D. J., Jukema, J. W., Trompet, S., Ford, I., Welsh, P., Sattar, N., Macfarlane, P. W., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1978 · Cited by 211
Rugge, J. B., Bougatsos, C., & Chou, R. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1456 · Cited by 172 · cited 3×
“However, the clinical symptoms of subclinical thyroid dysfunction are slight and uneven and can easily go unnoticed which might lead to controversy on screening and treatment of subclinical thyroid dysfunction in practice [8, 52].”
BackgroundBoekholdt, S. M., Titan, S. M., Wiersinga, W. M., Chatterjee, K., Basart, D. C. G., Luben, R., Wareham, N. J., & Khaw, K. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03640.x · Cited by 167 · cited 1×
“84) based on six studies [5, 21, 34, 38, 42, 43] (1369 CHD mortality events) (Figure 3(a)).”
Backgroundde Jongh, R. T., Lips, P., van Schoor, N. M., Rijs, K. J., Deeg, D. J. H., Comijs, H. C., Kramer, M. H. H., Vandenbroucke, J. P., & Dekkers, O. M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0430 · Cited by 157 · cited 2×
“84) based on six studies [5, 21, 34, 38, 42, 43] (1369 CHD mortality events) (Figure 3(a)).”
BackgroundHyland, K. A., Arnold, A. M., Lee, J. S., & Cappola, A. R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2180 · Cited by 127
Subclinical thyroid dysfunction and blood pressure: a community‐based study
Walsh, J. P., Bremner, A. P., Bulsara, M. K., O’Leary, P., Leedman, P. J., Feddema, P., & Michelangeli, V. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02619.x · Cited by 117
Åsvold, B. O., Bjøro, T., Platou, C., & Vatten, L. J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04477.x · Cited by 107 · cited 1×
“84) based on six studies [5, 21, 34, 38, 42, 43] (1369 CHD mortality events) (Figure 3(a)).”
BackgroundCardiovascular Events in Thyroid Disease: A Population Based, Prospective Study
Schultz, M., Kistorp, C., Raymond, I., Dimsits, J., Tuxen, C., Hildebrandt, P., & Faber, J. (2011) · Hormone and Metabolic Research · doi:10.1055/s-0031-1283162 · Cited by 67
Ceresini, G., Ceda, G. P., Lauretani, F., Maggio, M., Usberti, E., Marina, M., Bandinelli, S., Guralnik, J. M., Valenti, G., & Ferrucci, L. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12267 · Cited by 67
Yang, L.-B., Jiang, D.-Q., Qi, W.-B., Zhang, T., Feng, Y.-L., Gao, L., & Zhao, J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0015 · Cited by 56
Kaminski, G., Michalkiewicz, D., Makowski, K., Podgajny, Z., Szalus, N., Ruchala, M., Szczepanek, E., & Gielerak, G. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03957.x · Cited by 45 · cited 2×
“Subclinical hyperthyroidism also manifested in the cardiovascular system by numerous ways, including increased heart rate [17], left ventricular mass [18], susceptibility to endothelial dysfunction [19], and left ventricular diastolic dysfunction [20], which can cause changes in cardiovascular morphology and function.”
Background
Cited by
Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone?
Ettleson, M. D., & Bianco, A. C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa430 · Cited by 75
Overt and Subclinical Hypothyroidism in the Elderly: When to Treat
Calsolaro, V., Niccolai, F., Pasqualetti, G., Calabrese, A. M., Polini, A., Okoye, C., Magno, S., Caraccio, N., & Monzani, F. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00177 · Cited by 68
Sohn, S. Y., Lee, E., Lee, M. K., & Lee, J. H. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.728 · Cited by 60
“[45]; they showed that the risk of coronary heart disease mortality was higher in those aged less than 65 years.”
BackgroundResultThyroid and heart, a clinically relevant relationship
Corona, G., Croce, L., Sparano, C., Petrone, L., Sforza, A., Maggi, M., Chiovato, L., & Rotondi, M. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01590-9 · Cited by 60
Metadata
- Authors
- Sun, J., Yao, L., Fang, Y., Yang, R., Chen, Y., Yang, K., & Tian, L.
- Venue
- International Journal of Endocrinology
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-15
- ISSN
- 1687-8337 (ISSN-L)
- 1687-8345
- OpenAlex
- W2752076549
- Cited by
- 97
- References
- 26
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.